{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:21:25Z","timestamp":1757312485072,"version":"3.40.3"},"publisher-location":"Cham","reference-count":67,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030637606"},{"type":"electronic","value":"9783030637613"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-63761-3_15","type":"book-chapter","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T20:04:45Z","timestamp":1620677085000},"page":"243-261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["COVID-19 in Patients with Hypertension"],"prefix":"10.1007","author":[{"given":"Thiago","family":"Quinaglia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsima","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","unstructured":"Amat-Santos IJ, Santos-Martinez S, Lopez-Otero D, Nombela-Franco L, Gutierrez-Ibanes E, Del Valle R, Munoz-Garcia E, Jimenez-Diaz VA, Regueiro A, Gonzalez-Ferreiro R, Benito T, Sanmartin-Pena XC, Catala P, Rodriguez-Gabella T, Delgado-Arana JR, Carrasco-Moraleja M, Ibanez B, San Roman JA (2020) Ramipril in High Risk Patients with COVID-19. J Am Coll Cardiol. doi:https:\/\/doi.org\/10.1016\/j.jacc.2020.05.040","DOI":"10.1016\/j.jacc.2020.05.040"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijid.2016.06.015","volume":"49","author":"A Badawi","year":"2016","unstructured":"Badawi A, Ryoo SG (2016) Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis 49:129\u2013133. https:\/\/doi.org\/10.1016\/j.ijid.2016.06.015","journal-title":"Int J Infect Dis"},{"key":"15_CR3","doi-asserted-by":"publisher","unstructured":"Bello-Chavolla OY, Bahena-L\u00f3pez JP, Antonio-Villa NE, Vargas-V\u00e1zquez A, Gonz\u00e1lez-D\u00edaz A, M\u00e1rquez-Salinas A, Ferm\u00edn-Mart\u00ednez CA, Naveja JJ, Aguilar-Salinas CA (2020) Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgaa346","DOI":"10.1210\/clinem\/dgaa346"},{"key":"15_CR4","doi-asserted-by":"crossref","unstructured":"Bozkurt B, Kovacs R, Harrington B (2020) HFSA\/ACC\/AHA statement addresses concerns Re: using RAAS antagonists in COVID-19. American College of Cardiology (ACC)","DOI":"10.1016\/j.cardfail.2020.04.013"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"e4260","DOI":"10.1136\/bmj.e4260","volume":"345","author":"D Caldeira","year":"2012","unstructured":"Caldeira D, Alarc\u00e3o J, Vaz-Carneiro A, Costa J (2012) Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis. BMJ 345:e4260. https:\/\/doi.org\/10.1136\/bmj.e4260","journal-title":"BMJ"},{"issue":"6","key":"15_CR6","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1097\/CCM.0b013e3182451c87","volume":"40","author":"CS Calfee","year":"2012","unstructured":"Calfee CS, Gallagher D, Abbott J, Thompson BT, Matthay MA (2012) Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance. Crit Care Med 40(6):1731\u20131737. https:\/\/doi.org\/10.1097\/CCM.0b013e3182451c87","journal-title":"Crit Care Med"},{"key":"15_CR7","doi-asserted-by":"publisher","unstructured":"Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, Amadou C, Arnault G, Baudoux F, Bauduceau B, Borot S, Bourgeon-Ghittori M, Bourron O, Boutoille D, Cazenave-Roblot F, Chaumeil C, Cosson E, Coudol S, Darmon P, Disse E, Ducet-Boiffard A, Gaborit B, Joubert M, Kerlan V, Laviolle B, Marchand L, Meyer L, Potier L, Prevost G, Riveline JP, Robert R, Saulnier PJ, Sultan A, Th\u00e9baut JF, Thivolet C, Tramunt B, Vatier C, Roussel R, Gautier JF, Gourdy P (2020) Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia:1\u201316. https:\/\/doi.org\/10.1007\/s00125-020-05180-x","DOI":"10.1007\/s00125-020-05180-x"},{"key":"15_CR8","doi-asserted-by":"publisher","unstructured":"Chen D, Li X, Song Q, Hu C, Su F, Dai J (2020) Hypokalemia and clinical implications in patients with coronavirus disease 2019 (COVID-19). medRxiv:2020.2002.2027.20028530. doi:https:\/\/doi.org\/10.1101\/2020.02.27.20028530","DOI":"10.1101\/2020.02.27.20028530"},{"issue":"5","key":"15_CR9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","volume":"97","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G (2020) Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97(5):829\u2013838. https:\/\/doi.org\/10.1016\/j.kint.2020.03.005","journal-title":"Kidney Int"},{"key":"15_CR10","doi-asserted-by":"publisher","unstructured":"Darbani B (2020) The expression and polymorphism of entry machinery for COVID-19 in human: juxtaposing population groups, gender, and different tissues. Int J Environ Res Public Health 17(10). https:\/\/doi.org\/10.3390\/ijerph17103433","DOI":"10.3390\/ijerph17103433"},{"key":"15_CR11","unstructured":"De Simone G (2020) Position statement of the ESC council on hypertension on ACE-inhibitors and angiotensin receptor blockers. European society of cardiology, Council on hypertension,"},{"issue":"8","key":"15_CR12","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41577-019-0160-5","volume":"19","author":"GR Drummond","year":"2019","unstructured":"Drummond GR, Vinh A, Guzik TJ, Sobey CG (2019) Immune mechanisms of hypertension. Nature Rev Immunol 19(8):517\u2013532. https:\/\/doi.org\/10.1038\/s41577-019-0160-5","journal-title":"Nature Rev Immunol"},{"issue":"7","key":"15_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cardfail.2009.01.014","volume":"15","author":"S Epelman","year":"2009","unstructured":"Epelman S, Shrestha K, Troughton RW, Francis GS, Sen S, Klein AL, Tang WH (2009) Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes. J Card Fail 15(7):565\u2013571. https:\/\/doi.org\/10.1016\/j.cardfail.2009.01.014","journal-title":"J Card Fail"},{"issue":"4","key":"15_CR14","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/s2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8(4):e21. https:\/\/doi.org\/10.1016\/s2213-2600(20)30116-8","journal-title":"Lancet Respir Med"},{"issue":"21","key":"15_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.21037\/atm.2016.11.03","volume":"4","author":"DS Fedson","year":"2016","unstructured":"Fedson DS (2016) Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola. Ann Transl Med 4(21):421\u2013421. https:\/\/doi.org\/10.21037\/atm.2016.11.03","journal-title":"Ann Transl Med"},{"issue":"20","key":"15_CR16","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","volume":"111","author":"CM Ferrario","year":"2005","unstructured":"Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI, Gallagher PE (2005) Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 111(20):2605\u20132610. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.510461","journal-title":"Circulation"},{"issue":"6","key":"15_CR17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1161\/CIRCULATIONAHA.112.093245","volume":"126","author":"AJ Flammer","year":"2012","unstructured":"Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, Hamburg NM, Luscher TF, Shechter M, Taddei S, Vita JA, Lerman A (2012) The assessment of endothelial function: from research into clinical practice. Circulation 126(6):753\u2013767. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.093245","journal-title":"Circulation"},{"issue":"2","key":"15_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2016.19043","volume":"317","author":"MH Forouzanfar","year":"2017","unstructured":"Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, Alexander L, Estep K, Hassen Abate K, Akinyemiju TF, Ali R, Alvis-Guzman N, Azzopardi P, Banerjee A, Barnighausen T, Basu A, Bekele T, Bennett DA, Biadgilign S, Catala-Lopez F, Feigin VL, Fernandes JC, Fischer F, Gebru AA, Gona P, Gupta R, Hankey GJ, Jonas JB, Judd SE, Khang YH, Khosravi A, Kim YJ, Kimokoti RW, Kokubo Y, Kolte D, Lopez A, Lotufo PA, Malekzadeh R, Melaku YA, Mensah GA, Misganaw A, Mokdad AH, Moran AE, Nawaz H, Neal B, Ngalesoni FN, Ohkubo T, Pourmalek F, Rafay A, Rai RK, Rojas-Rueda D, Sampson UK, Santos IS, Sawhney M, Schutte AE, Sepanlou SG, Shifa GT, Shiue I, Tedla BA, Thrift AG, Tonelli M, Truelsen T, Tsilimparis N, Ukwaja KN, Uthman OA, Vasankari T, Venketasubramanian N, Vlassov VV, Vos T, Westerman R, Yan LL, Yano Y, Yonemoto N, Zaki ME, Murray CJ (2017) Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990\u20132015. JAMA 317(2):165\u2013182. https:\/\/doi.org\/10.1001\/jama.2016.19043","journal-title":"JAMA"},{"key":"15_CR19","doi-asserted-by":"publisher","unstructured":"Fox SE, Akmatbekov A, Harbert JL, Li G, Quincy Brown J, Vander Heide RS (2020) Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med. https:\/\/doi.org\/10.1016\/S2213-2600(20)30243-5","DOI":"10.1016\/S2213-2600(20)30243-5"},{"key":"15_CR20","doi-asserted-by":"publisher","unstructured":"Galloway JB, Norton S, Barker RD, Brookes A, Carey I, Clarke BD, Jina R, Reid C, Russell MD, Sneep R, Sugarman L, Williams S, Yates M, Teo J, Shah AM, Cantle F (2020) A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study. J Infect. https:\/\/doi.org\/10.1016\/j.jinf.2020.05.064","DOI":"10.1016\/j.jinf.2020.05.064"},{"key":"15_CR21","doi-asserted-by":"publisher","unstructured":"Gao C, Cai Y, Zhang K, Zhou L, Zhang Y, Zhang X, Li Q, Li W, Yang S, Zhao X, Zhao Y, Wang H, Liu Y, Yin Z, Zhang R, Wang R, Yang M, Hui C, Wijns W, McEvoy JW, Soliman O, Onuma Y, Serruys PW, Tao L, Li F (2020) Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa433","DOI":"10.1093\/eurheartj\/ehaa433"},{"issue":"3","key":"15_CR22","doi-asserted-by":"publisher","first-page":"L240","DOI":"10.1152\/ajplung.00187.2015","volume":"310","author":"I Gopallawa","year":"2016","unstructured":"Gopallawa I, Uhal BD (2016) Angiotensin-(1\u20137)\/mas inhibits apoptosis in alveolar epithelial cells through upregulation of MAP kinase phosphatase-2. Am J Physiol Lung Cell Mol Physiol 310(3):L240\u2013L248. https:\/\/doi.org\/10.1152\/ajplung.00187.2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"15_CR23","doi-asserted-by":"publisher","unstructured":"Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A (2020) Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. https:\/\/doi.org\/10.1001\/jama.2020.5394","DOI":"10.1001\/jama.2020.5394"},{"key":"15_CR24","doi-asserted-by":"publisher","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2002032","DOI":"10.1056\/NEJMoa2002032"},{"key":"15_CR25","doi-asserted-by":"publisher","unstructured":"Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z (2020) Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2020.1017","DOI":"10.1001\/jamacardio.2020.1017"},{"issue":"4","key":"15_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/08998280.2018.1499293","volume":"31","author":"C Henry","year":"2018","unstructured":"Henry C, Zaizafoun M, Stock E, Ghamande S, Arroliga AC, White HD (2018) Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia. Proceedings (Baylor University Medical Center) 31(4):419\u2013423. https:\/\/doi.org\/10.1080\/08998280.2018.1499293","journal-title":"Proceedings (Baylor University Medical Center)"},{"key":"15_CR27","doi-asserted-by":"publisher","unstructured":"Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, Hazzan AD, Fishbane S, Jhaveri KD (2020) Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. https:\/\/doi.org\/10.1016\/j.kint.2020.05.006","DOI":"10.1016\/j.kint.2020.05.006"},{"key":"15_CR28","doi-asserted-by":"publisher","unstructured":"Hoffmann M, Kleine-Weber H, Kr\u00fcger N, M\u00fcller M, Drosten C, P\u00f6hlmann S (2020) The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv:2020.2001.2031.929042. https:\/\/doi.org\/10.1101\/2020.01.31.929042","DOI":"10.1101\/2020.01.31.929042"},{"key":"15_CR29","doi-asserted-by":"publisher","unstructured":"Hu J, Zhang X, Zhang X, Zhao H, Lian J, Hao S, Jia H, Yang M, Lu Y, Xiang D, Cai H, Zhang S, Gu J, Ye C, Yu G, Jin C, Zheng L, Yang Y, Sheng J (2020) COVID-19 patients with hypertension have more severity condition, and ACEI\/ARB treatment have no influence on the clinical severity and outcome. J Infect. https:\/\/doi.org\/10.1016\/j.jinf.2020.05.056","DOI":"10.1016\/j.jinf.2020.05.056"},{"issue":"3","key":"15_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005035","volume":"11","author":"T Huan","year":"2015","unstructured":"Huan T, Esko T, Peters MJ, Pilling LC, Schramm K, Schurmann C, Chen BH, Liu C, Joehanes R, Johnson AD, Yao C, Ying SX, Courchesne P, Milani L, Raghavachari N, Wang R, Liu P, Reinmaa E, Dehghan A, Hofman A, Uitterlinden AG, Hernandez DG, Bandinelli S, Singleton A, Melzer D, Metspalu A, Carstensen M, Grallert H, Herder C, Meitinger T, Peters A, Roden M, Waldenberger M, D\u00f6rr M, Felix SB, Zeller T, Vasan R, O\u2019Donnell CJ, Munson PJ, Yang X, Prokisch H, V\u00f6lker U, van Meurs JB, Ferrucci L, Levy D (2015) A meta-analysis of gene expression signatures of blood pressure and hypertension. PLoS Genet 11(3):e1005035. https:\/\/doi.org\/10.1371\/journal.pgen.1005035","journal-title":"PLoS Genet"},{"issue":"10223","key":"15_CR31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020a) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England) 395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet (London, England)"},{"key":"15_CR32","doi-asserted-by":"publisher","unstructured":"Huang S, Wang J, Liu F, Liu J, Cao G, Yang C, Liu W, Tu C, Zhu M, Xiong B (2020b) COVID-19 patients with hypertension have more severe disease: a multi-center retrospective observational study. Hypertens Res. https:\/\/doi.org\/10.1038\/s41440-020-0485-2","DOI":"10.1038\/s41440-020-0485-2"},{"key":"15_CR33","doi-asserted-by":"publisher","unstructured":"Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, Cani DS, Cerini M, Farina D, Gavazzi E, Maroldi R, Adamo M, Ammirati E, Sinagra G, Lombardi CM, Metra M (2020) Cardiac Involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2020.1096","DOI":"10.1001\/jamacardio.2020.1096"},{"issue":"5","key":"15_CR34","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","volume":"43","author":"Y Ishiyama","year":"2004","unstructured":"Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM (2004) Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension 43(5):970\u2013976. https:\/\/doi.org\/10.1161\/01.HYP.0000124667.34652.1a","journal-title":"Hypertension"},{"key":"15_CR35","doi-asserted-by":"publisher","unstructured":"Kai H, Kai M (2020) Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19. Hypertens Res:1\u20137. https:\/\/doi.org\/10.1038\/s41440-020-0455-8","DOI":"10.1038\/s41440-020-0455-8"},{"key":"15_CR36","doi-asserted-by":"publisher","unstructured":"Kang Y, Chen T, Mui D, Ferrari V, Jagasia D, Scherrer-Crosbie M, Chen Y, Han Y (2020) Cardiovascular manifestations and treatment considerations in covid-19. Heart. https:\/\/doi.org\/10.1136\/heartjnl-2020-317,056","DOI":"10.1136\/heartjnl-2020-317,056"},{"issue":"4","key":"15_CR37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0002-9343(94)90060-4","volume":"96","author":"I Koivula","year":"1994","unstructured":"Koivula I, Sten M, M\u00e4kel\u00e4 PH (1994) Risk factors for pneumonia in the elderly. Am J Med 96(4):313\u2013320. https:\/\/doi.org\/10.1016\/0002-9343(94)90060-4","journal-title":"Am J Med"},{"issue":"8","key":"15_CR38","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L, Zhang B, Liu G, Wang Z, Chappell M, Liu Y, Zheng D, Leibbrandt A, Wada T, Slutsky AS, Liu D, Qin C, Jiang C, Penninger JM (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 11(8):875\u2013879. https:\/\/doi.org\/10.1038\/nm1267","journal-title":"Nat Med"},{"issue":"8","key":"15_CR39","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jamda.2015.05.009","volume":"16","author":"JS Lee","year":"2015","unstructured":"Lee JS, Chui PY, Ma HM, Auyeung TW, Kng C, Law T, Ng LK, Tam KF, Tang WH, Chan BY, Tong MC, Wong KT, Yuen YH, Yuk KL, Kwok T (2015) Does low dose angiotensin converting enzyme inhibitor prevent pneumonia in older people with neurologic dysphagia\u2013a randomized placebo-controlled trial. J Am Med Dir Assoc 16(8):702\u2013707. https:\/\/doi.org\/10.1016\/j.jamda.2015.05.009","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"15_CR40","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","volume":"109","author":"B Li","year":"2020","unstructured":"Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z, Zhao Y (2020) Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 109(5):531\u2013538. https:\/\/doi.org\/10.1007\/s00392-020-01626-9","journal-title":"Clin Res Cardiol"},{"issue":"6","key":"15_CR41","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/00004872-199,606,000-00017","volume":"14","author":"M Luque","year":"1996","unstructured":"Luque M, Martin P, Martell N, Fernandez C, Brosnihan KB, Ferrario CM (1996) Effects of captopril related to increased levels of prostacyclin and angiotensin-(1\u20137) in essential hypertension. J Hypertens 14(6):799\u2013805. https:\/\/doi.org\/10.1097\/00004872-199,606,000-00017","journal-title":"J Hypertens"},{"key":"15_CR42","doi-asserted-by":"publisher","unstructured":"Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G (2020) Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2006923","DOI":"10.1056\/NEJMoa2006923"},{"key":"15_CR43","doi-asserted-by":"publisher","unstructured":"Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1127","DOI":"10.1001\/jamaneurol.2020.1127"},{"key":"15_CR44","doi-asserted-by":"publisher","unstructured":"Martinez-Ferran M, de la Gu\u00eda-Galipienso F, Sanchis-Gomar F, Pareja-Galeano H (2020) Metabolic impacts of confinement during the COVID-19 pandemic due to modified diet and physical activity habits. Nutrients 12 (6). doi:https:\/\/doi.org\/10.3390\/nu12061549","DOI":"10.3390\/nu12061549"},{"key":"15_CR45","doi-asserted-by":"publisher","unstructured":"Mehta N, Kalra A, Nowacki AS, Anjewierden S, Han Z, Bhat P, Carmona-Rubio AE, Jacob M, Procop GW, Harrington S, Milinovich A, Svensson LG, Jehi L, Young JB, Chung MK (2020) Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2020.1855","DOI":"10.1001\/jamacardio.2020.1855"},{"key":"15_CR46","doi-asserted-by":"publisher","first-page":"f5061","DOI":"10.1136\/bmj.f5061","volume":"347","author":"D Mertz","year":"2013","unstructured":"Mertz D, Kim TH, Johnstone J, Lam P-P, Science M, Kuster SP, Fadel SA, Tran D, Fernandez E, Bhatnagar N, Loeb M (2013) Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ 347:f5061\u2013f5061. https:\/\/doi.org\/10.1136\/bmj.f5061","journal-title":"BMJ"},{"issue":"11","key":"15_CR47","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1093\/cid\/cis733","volume":"55","author":"EM Mortensen","year":"2012","unstructured":"Mortensen EM, Nakashima B, Cornell J, Copeland LA, Pugh MJ, Anzueto A, Good C, Restrepo MI, Downs JR, Frei CR, Fine MJ (2012) Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes. Clin Infect Dis 55(11):1466\u20131473. https:\/\/doi.org\/10.1093\/cid\/cis733","journal-title":"Clin Infect Dis"},{"issue":"9","key":"15_CR48","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1164\/rccm.200309-1219OC","volume":"169","author":"T Ohkubo","year":"2004","unstructured":"Ohkubo T, Chapman N, Neal B, Woodward M, Omae T, Chalmers J, Perindopril Protection Against Recurrent Stroke Study Collaborative G (2004) Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. Am J Respir Crit Care Med 169(9):1041\u20131045. https:\/\/doi.org\/10.1164\/rccm.200309-1219OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"15_CR49","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.tips.2015.03.001","volume":"36","author":"DG Passos-Silva","year":"2015","unstructured":"Passos-Silva DG, Brandan E, Santos RA (2015) Angiotensins as therapeutic targets beyond heart disease. Trends Pharmacol Sci 36(5):310\u2013320. https:\/\/doi.org\/10.1016\/j.tips.2015.03.001","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"15_CR50","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/ajh.2011.188","volume":"25","author":"SK Patel","year":"2012","unstructured":"Patel SK, Wai B, Ord M, MacIsaac RJ, Grant S, Velkoska E, Panagiotopoulos S, Jerums G, Srivastava PM, Burrell LM (2012) Association of ACE2 genetic variants with blood pressure, left ventricular mass, and cardiac function in Caucasians with type 2 diabetes. Am J Hypertens 25(2):216\u2013222. https:\/\/doi.org\/10.1038\/ajh.2011.188","journal-title":"Am J Hypertens"},{"issue":"6","key":"15_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198144","volume":"13","author":"J Ramchand","year":"2018","unstructured":"Ramchand J, Patel SK, Srivastava PM, Farouque O, Burrell LM (2018) Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease. PLoS One 13(6):e0198144. https:\/\/doi.org\/10.1371\/journal.pone.0198144","journal-title":"PLoS One"},{"key":"15_CR52","doi-asserted-by":"publisher","unstructured":"Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, Hausvater A, Newman JD, Berger JS, Bangalore S, Katz SD, Fishman GI, Kunichoff D, Chen Y, Ogedegbe G, Hochman JS (2020) Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2008975","DOI":"10.1056\/NEJMoa2008975"},{"key":"15_CR53","doi-asserted-by":"publisher","unstructured":"Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, Barnaby DP, Becker LB, Chelico JD, Cohen SL, Cookingham J, Coppa K, Diefenbach MA, Dominello AJ, Duer-Hefele J, Falzon L, Gitlin J, Hajizadeh N, Harvin TG, Hirschwerk DA, Kim EJ, Kozel ZM, Marrast LM, Mogavero JN, Osorio GA, Qiu M, Zanos TP (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized With COVID-19 in the New York City Area. JAMA. https:\/\/doi.org\/10.1001\/jama.2020.6775","DOI":"10.1001\/jama.2020.6775"},{"key":"15_CR54","doi-asserted-by":"publisher","unstructured":"Rodriguez-Morales AJ, Cardona-Ospina JA, Gutierrez-Ocampo E, Villamizar-Pena R, Holguin-Rivera Y, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Franco-Paredes C, Henao-Martinez AF, Paniz-Mondolfi A, Lagos-Grisales GJ, Ramirez-Vallejo E, Suarez JA, Zambrano LI, Villamil-Gomez WE, Balbin-Ramon GJ, Rabaan AA, Harapan H, Dhama K, Nishiura H, Kataoka H, Ahmad T, Sah R (2020) Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis:101623. https:\/\/doi.org\/10.1016\/j.tmaid.2020.101623","DOI":"10.1016\/j.tmaid.2020.101623"},{"issue":"5","key":"15_CR55","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","volume":"46","author":"Q Ruan","year":"2020","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 46(5):846\u2013848. https:\/\/doi.org\/10.1007\/s00134-020-05991-x","journal-title":"Intensive Care Med"},{"key":"15_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104832","volume":"156","author":"JM Saavedra","year":"2020","unstructured":"Saavedra JM (2020) Angiotensin receptor blockers and COVID-19. Pharmacol Res 156:104832. https:\/\/doi.org\/10.1016\/j.phrs.2020.104832","journal-title":"Pharmacol Res"},{"issue":"2","key":"15_CR57","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s15010-020-01391-x","volume":"48","author":"B Schulte-Hubbert","year":"2020","unstructured":"Schulte-Hubbert B, Meiswinkel N, Kutschan U, Kolditz M (2020) Prognostic value of blood pressure drops during the first 24 h after hospital admission for risk stratification of community-acquired pneumonia: a retrospective cohort study. Infection 48(2):267\u2013274. https:\/\/doi.org\/10.1007\/s15010-020-01391-x","journal-title":"Infection"},{"issue":"6","key":"15_CR58","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1161\/ATVBAHA.120.314330","volume":"40","author":"Y Shao","year":"2020","unstructured":"Shao Y, Saredy J, Yang WY, Sun Y, Lu Y, Saaoud F, Drummer C, Johnson C, Xu K, Jiang X, Wang H, Yang X (2020) Vascular endothelial cells and innate immunity. Arterioscler Thromb Vasc Biol 40(6):e138\u2013e152. https:\/\/doi.org\/10.1161\/ATVBAHA.120.314330","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"15_CR59","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/bph.12159","volume":"169","author":"A Sim\u00f5es e Silva","year":"2013","unstructured":"Sim\u00f5es e Silva A, Silveira K, Ferreira A, Teixeira M (2013) ACE2, angiotensin-(1\u20137) and Mas receptor axis in inflammation and fibrosis. Br J Pharmacol 169(3):477\u2013492. https:\/\/doi.org\/10.1111\/bph.12159","journal-title":"Br J Pharmacol"},{"issue":"17","key":"15_CR60","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","volume":"382","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD (2020) Renin\u2013angiotensin\u2013aldosterone system inhibitors in patients with Covid-19. New England Journal of Medicine 382(17):1653\u20131659. https:\/\/doi.org\/10.1056\/NEJMsr2005760","journal-title":"New England Journal of Medicine"},{"issue":"10234","key":"15_CR61","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395(10234):1417\u20131418. https:\/\/doi.org\/10.1016\/S0140-6736(20)30937-5","journal-title":"Lancet"},{"issue":"8","key":"15_CR62","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/europace\/euw246","volume":"19","author":"TE Walters","year":"2017","unstructured":"Walters TE, Kalman JM, Patel SK, Mearns M, Velkoska E, Burrell LM (2017) Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling. Europace 19(8):1280\u20131287. https:\/\/doi.org\/10.1093\/europace\/euw246","journal-title":"Europace"},{"key":"15_CR63","doi-asserted-by":"publisher","unstructured":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. https:\/\/doi.org\/10.1001\/jamainternmed.2020.0994","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"15_CR64","doi-asserted-by":"publisher","unstructured":"Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, Ji R, Wang H, Wang Y, Zhou Y (2020) Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. https:\/\/doi.org\/10.1016\/j.ijid.2020.03.017","DOI":"10.1016\/j.ijid.2020.03.017"},{"key":"15_CR65","doi-asserted-by":"publisher","unstructured":"Zhang P, Zhu L, Cai J, Lei F, Qin J-J, Xie J, Liu Y-M, Zhao Y-C, Huang X, Lin L, Xia M, Chen M-M, Cheng X, Zhang X, Guo D, Peng Y, Ji Y-X, Chen J, She Z-G, Wang Y, Xu Q, Tan R, Wang H, Lin J, Luo P, Fu S, Cai H, Ye P, Xiao B, Mao W, Liu L, Yan Y, Liu M, Chen M, Zhang X-J, Wang X, Touyz RM, Xia J, Zhang B-H, Huang X, Yuan Y, Rohit L, Liu PP, Li H (2020) Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin ii receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res 126:1671\u20131681. doi:https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317134","DOI":"10.1161\/CIRCRESAHA.120.317134"},{"issue":"10229","key":"15_CR66","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/s0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054\u20131062. https:\/\/doi.org\/10.1016\/s0140-6736(20)30566-3","journal-title":"Lancet"},{"issue":"2","key":"15_CR67","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","volume":"14","author":"X Zou","year":"2020","unstructured":"Zou X, Chen K, Zou J, Han P, Hao J, Han Z (2020) Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med 14(2):185\u2013192. https:\/\/doi.org\/10.1007\/s11684-020-0754-0","journal-title":"Front Med"}],"container-title":["Advances in Experimental Medicine and Biology","Coronavirus Disease - COVID-19"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-63761-3_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T08:07:56Z","timestamp":1639555676000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-63761-3_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030637606","9783030637613"],"references-count":67,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-63761-3_15","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"11 May 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}